These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7548064)

  • 1. Structural factors contributing to the hydrophobic effect: the partly exposed hydrophobic minicore in chymotrypsin inhibitor 2.
    Otzen DE; Rheinnecker M; Fersht AR
    Biochemistry; 1995 Oct; 34(40):13051-8. PubMed ID: 7548064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cavity-creating mutations in the hydrophobic core of chymotrypsin inhibitor 2.
    Jackson SE; Moracci M; elMasry N; Johnson CM; Fersht AR
    Biochemistry; 1993 Oct; 32(42):11259-69. PubMed ID: 8218191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the hydrophobic core in the transition state for folding of chymotrypsin inhibitor 2: a critical test of the protein engineering method of analysis.
    Jackson SE; elMasry N; Fersht AR
    Biochemistry; 1993 Oct; 32(42):11270-8. PubMed ID: 8218192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the intramolecular hydrogen bond network in the inhibitory power of chymotrypsin inhibitor 2.
    Radisky ES; Lu CJ; Kwan G; Koshland DE
    Biochemistry; 2005 May; 44(18):6823-30. PubMed ID: 15865427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain in the folding nucleus of chymotrypsin inhibitor 2.
    Ladurner AG; Itzhaki LS; Fersht AR
    Fold Des; 1997; 2(6):363-8. PubMed ID: 9427010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Context dependence of protein secondary structure formation: the three-dimensional structure and stability of a hybrid between chymotrypsin inhibitor 2 and helix E from subtilisin Carlsberg.
    Osmark P; Sørensen P; Poulsen FM
    Biochemistry; 1993 Oct; 32(41):11007-14. PubMed ID: 8218165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: evidence for a nucleation-condensation mechanism for protein folding.
    Itzhaki LS; Otzen DE; Fersht AR
    J Mol Biol; 1995 Nov; 254(2):260-88. PubMed ID: 7490748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct comparison of experimental and calculated folding free energies for hydrophobic deletion mutants of chymotrypsin inhibitor 2: free energy perturbation calculations using transition and denatured states from molecular dynamics simulations of unfolding.
    Pan Y; Daggett V
    Biochemistry; 2001 Mar; 40(9):2723-31. PubMed ID: 11258883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
    Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
    Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The folding of an enzyme. II. Substructure of barnase and the contribution of different interactions to protein stability.
    Serrano L; Kellis JT; Cann P; Matouschek A; Fersht AR
    J Mol Biol; 1992 Apr; 224(3):783-804. PubMed ID: 1569557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
    Longstaff C; Campbell AF; Fersht AR
    Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of residues in the reactive site loop of chymotrypsin inhibitor 2 to protein stability and activity.
    Jackson SE; Fersht AR
    Biochemistry; 1994 Nov; 33(46):13880-7. PubMed ID: 7947796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of arginine 67 in the stabilization of chymotrypsin inhibitor 2: examination of amide proton exchange rates and denaturation thermodynamics of an engineered protein.
    Jandu SK; Ray S; Brooks L; Leatherbarrow RJ
    Biochemistry; 1990 Jul; 29(26):6264-9. PubMed ID: 2207072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Context-dependent nature of destabilizing mutations on the stability of FKBP12.
    Main ER; Fulton KF; Jackson SE
    Biochemistry; 1998 Apr; 37(17):6145-53. PubMed ID: 9558354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of serine proteinase-inhibitor interaction by alanine shaving.
    Buczek O; Koscielska-Kasprzak K; Krowarsch D; Dadlez M; Otlewski J
    Protein Sci; 2002 Apr; 11(4):806-19. PubMed ID: 11910024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure of the transition state for the association of two fragments of the barley chymotrypsin inhibitor 2 to generate native-like protein: implications for mechanisms of protein folding.
    de Prat Gay G; Ruiz-Sanz J; Davis B; Fersht AR
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10943-6. PubMed ID: 7971988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the protein core in the inhibitory power of the classic serine protease inhibitor, chymotrypsin inhibitor 2.
    Radisky ES; King DS; Kwan G; Koshland DE
    Biochemistry; 2003 Jun; 42(21):6484-92. PubMed ID: 12767231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the correlation between delta A and delta V of protein unfolding using m value mutants of staphylococcal nuclease.
    Frye KJ; Perman CS; Royer CA
    Biochemistry; 1996 Aug; 35(31):10234-9. PubMed ID: 8756489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophobic core substitutions in calbindin D9k: effects on stability and structure.
    Julenius K; Thulin E; Linse S; Finn BE
    Biochemistry; 1998 Jun; 37(25):8915-25. PubMed ID: 9636033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.